The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.897042
Abstract: Background Glioma is an incurable malignant lesion with poor outcome characterized by easy recurrence after surgery with or without radiotherapy and chemotherapy. Studies have shown that COL6A2 is closely related to the tumorigenesis and development… read more here.
Keywords: immune genes; col6a2 expression; col6a2; glioma ... See more keywords